Ftse Mib
35.143,06
-0,49%
DAX
20.214,79
-0,51%
S&P 500
5.843,08
-1,27%
NASDAQ
19.284,79
-1,00%
Bitcoin
94.789,20
2,57%
Pepperstone
Advertisement
Registration Strip Icon for discussion Registrati per interagire nei nostri forum attivi per discutere con investitori con idee simili.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Tempus AI Inc (TEM) Tempus AI Inc (TEM) Notizie

Tempus AI Inc

TEM
37,80
0,31 (0,83%)
Ultimo aggiornamento: 20:01:15
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
08/1/202522:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202517:58BWTempus Announces a Collaboration With Genialis to Develop..
08/1/202514:30BWTempus Announces a Collaboration With Genialis to Develop..
07/1/202514:30BWTempus to Present at 43rd Annual J.P. Morgan Healthcare..
03/1/202522:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202501:19EDGAR2Form 144 - Report of proposed sale of securities
19/12/202402:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202402:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202402:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202402:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/12/202402:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202414:30BWTempus Now an In-Network Provider for Blue Cross Blue Shield..
17/12/202414:30BWNew CMS Decision Provides Medicare Coverage for the Clinical..
16/12/202414:00BWPersonalis and Tempus Expand Collaboration to Biopharma
14/12/202400:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202400:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202400:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202400:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/12/202400:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12/12/202422:48EDGAR2Form 144 - Report of proposed sale of securities
11/12/202423:03EDGAR2Form 144 - Report of proposed sale of securities
11/12/202423:02EDGAR2Form 144 - Report of proposed sale of securities
11/12/202423:01EDGAR2Form 144 - Report of proposed sale of securities
11/12/202423:01EDGAR2Form 144 - Report of proposed sale of securities
11/12/202423:01EDGAR2Form 144 - Report of proposed sale of securities
25/11/202414:30BWTempus to Participate in the Piper Sandler 36th Annual..
12/11/202422:30EDGAR2Form SC 13G - Statement of Beneficial Ownership by Certain..
12/11/202414:30BWTempus Molecular Profiling Integration Now Available Through..
11/11/202414:30BWTempus Publishes Study Highlighting Benefits of Concurrent..
08/11/202414:30BWTempus Announces Nine Abstracts Accepted for Presentation at..
07/11/202422:30BWTempus Announces the Clinical Launch of its Immune Profile..
05/11/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/11/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/11/202422:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/11/202422:05EDGAR2Form 8-K - Current report
04/11/202422:02EDGAR2Form 8-K - Current report
04/11/202422:01BWTempus Reports Third Quarter 2024 Results and Agreement to..
04/11/202402:06BWTempus to Report Third Quarter 2024 Financial Results on..
24/10/202414:30BWTempus to Report Third Quarter 2024 Financial Results on..
26/9/202414:30BWTempus Announces Expansion of Collaboration with Takeda to..
12/9/202414:30BWTempus Launches Beta Version of olivia, its AI-enabled..
06/9/202422:06EDGAR2Form 8-K - Current report
04/9/202414:30BWTempus Announces Real World Data Collaboration with BioNTech
28/8/202414:30BWTempus to Present at the Morgan Stanley 22nd Annual Global..
08/8/202414:30BWNPJ Precision Oncology Publishes Tempus Study on Validation..
06/8/202422:01BWTempus Reports Second Quarter 2024 Results
01/8/202414:30BWTempus Next Launches New Algorithm to Close Care Gaps in..
30/7/202414:30BWTempus Announces Expanded Data and Sequencing Collaboration..
17/7/202415:30BWTempus to Report Second Quarter 2024 Financial Results on..
Apertura: 36,65 Min: 34,82 Max: 37,97
Chiusura: 37,49

La tua Cronologia

NASDAQ
TEM
Tempus AI
LSE
0K6R
Neurocrine Biosciences
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network